Pharmacological treatments for tobacco dependence
نویسنده
چکیده
There are currently three licensed therapies for smoking cessation: nicotine replacement (NR), bupropion and varenicline. NR can be indicated for: 1) aid in abrupt cessation; 2) gradual reduction in order to quit smoking; 3) temporary abstinence; and 4) smoking reduction maintenance. A meta-analysis has found that the relative risk of abstinence for any form of NR relative to control was 1.6. It has been found that starting NR treatment 1–3 weeks before smoking cessation and combining NR products, usually patch and gum, increases efficacy. Recently some new nicotine administration forms, i.e. lozenge, mouth spray and a pouch, have been developed. They seem to have the potential to relieve cravings faster than the current high-dose gum, and also be more preferred. Varenicline is a selective partial agonist at the a4b2 nicotinic acetylcholine receptors (nAChR). It decreases cravings and alleviates the symptoms of withdrawal. It can also reduce the rewarding and reinforcing effects of nicotine. Trials have shown varenicline to have increased efficacy relative to bupropion. Varenicline has also been compared with NR (21 mg transdermal patch) in one randomised study. Abstinence at the end of treatment at 12 weeks was significantly increased for varenicline (56%) compared with for nicotine patch (43%). Some post-marketing reports have expressed concern about psychiatric adverse effects, such as aggression, depression and suicides. The European Medicines Agency and the Food and Drug Administration of the USA are monitoring reported side-effects, but so far no confirmed casual relationship between these adverse effects and varenicline has been established. Bupropion inhibits neuronal re-uptake of dopamine and norepinephrine and is an antagonist on the nAChR. Its efficacy, compared with placebo, has been proved in several meta-analyses. A recent study suggests that longer pre-cessation use of bupropion, e.g. for 4 weeks, can improve
منابع مشابه
POLICY RECOMMENDATIONS FOR SMOKING CESSATION AND TREATMENT OF TOBACCO DEPENDENCE A review of the evidence base of effective smoking cessation and treatment of tobacco dependence demonstrates that behavioural and pharmacological therapies
A review of the evidence base of effective smoking cessation and treatment of tobacco dependence demonstrates that behavioural and pharmacological therapies for tobacco dependence can contribute substantially to greater health gains. A number of authoritative bodies have reviewed efficacious and highly cost-effective treatments. These reviews advocate that all health-care personnel and clinicia...
متن کاملEffectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial
BACKGROUND Tobacco dependence management is a multi-component intervention that includes pharmacological treatments such as Nicotine Substitution Therapy (NST) or bupropion, and psychological therapy. There are some preliminary reports on topiramate efficacy for tobacco dependence. The aim of this study is to determine whether topiramate is as effective as the standard NST treatment for tobacco...
متن کاملManaging nicotine addiction.
Nicotine addiction has been identified as the primary contributor to continued widespread tobacco use worldwide. Although the health benefits of smoking cessation are well publicized, few smokers successfully quit on a long-term basis. A number of pharmacological agents have been shown to approximately double long-term smoking cessation rates and have, therefore, been recommended as first-line ...
متن کاملPhysician and enrollee knowledge of Medicaid coverage for tobacco dependence treatments.
BACKGROUND The 2000 Public Health Service Clinical Practice Guideline, Treating Tobacco Use and Dependence, recommends health insurance coverage for tobacco-dependence treatments proven effective in helping smokers to quit. Two states with comprehensive coverage for tobacco-dependence treatments in their Medicaid programs were selected to document awareness of coverage for tobacco-dependence tr...
متن کاملReduced-nicotine content cigarettes: Is there potential to aid smoking cessation?
INTRODUCTION Current smoking cessation treatments largely address pharmacological dependence on nicotine. New approaches are needed that address both nicotine dependence and psychological dependence on cigarettes as the source of nicotine. One such approach is the use of cigarettes with reduced nicotine content. METHODS We reviewed the available literature on the use of reduced-nicotine conte...
متن کاملTreatment of tobacco use and dependence: the role of the dental professional.
The purpose of this article is to discuss tobacco use and dependence, effective treatments, and the role of the dental professional. Tobacco dependence is discussed as a chronic condition characterized by a vulnerability to relapse that persists for perhaps years. The need for ongoing rather than just acute care is highlighted. Effective treatments for tobacco dependence exist. Brief clinical i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009